Jessica Young from Quantify Research’s Stockholm office had a fantastic time at last week’s International Society for Pharmacoepidemiology‘s annual meeting, reconnecting with colleagues, meeting new faces, and diving into engaging discussions around the role […]
Last week the team came together to give the office plants some much needed TLC.
Turns out there are a fair few green fingers at Quantify!
Whilst we might not be adding gardening to […]
Quantify’s Mathias Lilja and Johan Mesterton are co-authors on a new study on cytarabine dosing for treating secondary and high-risk AML using a synthetic control arm study design.
Since 1980’s, the standard treatment of acute myeloid leukemia (AML) is cytarabine infusion […]
Our capabilities have significantly expanded, allowing us to offer comprehensive support for your Finnish data and access needs.
As the leading provider of Nordic RWE and market access services, we’ve strengthened our Finnish presence to deliver:
▪ End-to-end RWE including patient-level data […]
The Nordic region (often called Scandinavia) is home to some of the world’s best real-world data (RWD), driving the development of pharmaceuticals and medical devices. As high-quality RWD becomes increasingly important to regulators and payers, it is critical for real-world evidence […]
We have an exciting and action-packed fall ahead of us, including:
– Growing our global service offering (including our newest office in Finland!)
– Annual September Kick-off
– Leadership training for senior staff
– A number of conferences, such as ISPOR EU, DIA RWE […]
Last week a whooping 3 teams of Quantify Research colleagues took part in the annual Convini relay race in Stora Skuggan in Stockholm – our biggest turnout yet!
A relay race truly embodies what we […]
Quantify Research is excited to announce a new partnership with Gylfi Ólafsson, an expert in the Icelandic health care system and RWD landscape.
Gylfi holds a PhD […]
Last week we welcomed Katja Nolvi to the Helsinki office.
Katja is a seasoned professional with nearly 20 years of experience in the pharmaceutical industry, specializing in Real-World Evidence, Market Access, Health Economics, and Outcomes Research (HEOR). Her career spans a […]